SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004560
Filing Date
2019-04-01
Accepted
2019-04-01 16:53:50
Documents
69
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2030899
2 form10-k_001.jpg GRAPHIC 14190
3 form10-k_002.jpg GRAPHIC 15343
4 ex21-1.htm EX-21.1 5198
5 ex23-1.htm EX-23.1 3733
6 ex31-1.htm EX-31.1 11492
7 ex31-2.htm EX-31.2 11634
8 ex32-1.htm EX-32.1 10638
  Complete submission text file 0001493152-19-004560.txt   5591397

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE mtnb-20181231.xml EX-101.INS 605156
10 XBRL SCHEMA FILE mtnb-20181231.xsd EX-101.SCH 50958
11 XBRL CALCULATION FILE mtnb-20181231_cal.xml EX-101.CAL 62845
12 XBRL DEFINITION FILE mtnb-20181231_def.xml EX-101.DEF 247034
13 XBRL LABEL FILE mtnb-20181231_lab.xml EX-101.LAB 396225
14 XBRL PRESENTATION FILE mtnb-20181231_pre.xml EX-101.PRE 321366
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38022 | Film No.: 19721457
SIC: 2834 Pharmaceutical Preparations